Temasek Holdings Private Ltd boosted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 416.4% during the 1st quarter, HoldingsChannel.com reports. The fund owned 227,211 shares of the medical equipment provider’s stock after purchasing an additional 183,211 shares during the quarter. Temasek Holdings Private Ltd’s holdings in Intuitive Surgical were worth $104,742,000 at the end of the most recent quarter.
Several other institutional investors have also added to or reduced their stakes in ISRG. Newbridge Financial Services Group Inc. lifted its position in shares of Intuitive Surgical by 300.0% in the 4th quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 33 shares during the period. Olistico Wealth LLC purchased a new position in shares of Intuitive Surgical during the fourth quarter valued at about $28,000. Main Street Group LTD bought a new position in Intuitive Surgical in the first quarter worth about $30,000. Laurel Wealth Advisors LLC bought a new position in Intuitive Surgical in the fourth quarter worth about $31,000. Finally, Vermillion Wealth Management Inc. lifted its holdings in Intuitive Surgical by 58.1% in the first quarter. Vermillion Wealth Management Inc. now owns 68 shares of the medical equipment provider’s stock worth $31,000 after buying an additional 25 shares during the period. 83.64% of the stock is currently owned by institutional investors.
Insider Activity at Intuitive Surgical
In other Intuitive Surgical news, Director Amy L. Ladd sold 500 shares of the business’s stock in a transaction on Tuesday, April 28th. The stock was sold at an average price of $473.46, for a total value of $236,730.00. Following the sale, the director directly owned 239 shares of the company’s stock, valued at approximately $113,156.94. The trade was a 67.66% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Iman Jeddi sold 5,625 shares of the stock in a transaction on Monday, June 1st. The stock was sold at an average price of $420.55, for a total value of $2,365,593.75. Following the completion of the sale, the senior vice president directly owned 6,463 shares in the company, valued at approximately $2,718,014.65. This represents a 46.53% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 7,169 shares of company stock valued at $3,059,135 in the last 90 days. Corporate insiders own 0.60% of the company’s stock.
Key Stories Impacting Intuitive Surgical
- Positive Sentiment: Recent commentary highlights that Intuitive Surgical’s latest earnings were impressive, with the company continuing to post strong growth and beating expectations, which supports the long-term investment case. Article Title
- Positive Sentiment: Analysts and recent coverage argue the stock may be oversold, with Wall Street estimate revisions moving higher and some writers saying the pullback could create a buying opportunity for growth investors. Article Title
- Positive Sentiment: One valuation-focused piece says ISRG is being priced for slower growth than it is currently delivering, suggesting the stock could be undervalued if the company maintains its current pace. Article Title
- Neutral Sentiment: Multiple articles note that ISRG has become a heavily watched and widely discussed stock, reflecting heightened investor attention rather than a clear new business catalyst. Article Title
- Negative Sentiment: Despite the strong fundamentals, the stock has fallen sharply over the past several weeks, and several reports frame the decline as a correction driven by investor caution around valuation and recent price weakness. Article Title
Wall Street Analysts Forecast Growth
Several research firms have weighed in on ISRG. Mizuho set a $500.00 price objective on Intuitive Surgical and gave the company a “neutral” rating in a research report on Wednesday, July 15th. Leerink Partners decreased their target price on Intuitive Surgical from $573.00 to $454.00 and set an “outperform” rating for the company in a research report on Friday, July 17th. Weiss Ratings restated a “hold (c)” rating on shares of Intuitive Surgical in a research note on Tuesday, May 19th. Evercore set a $430.00 price target on Intuitive Surgical in a research note on Monday, July 6th. Finally, Royal Bank Of Canada decreased their price objective on Intuitive Surgical from $650.00 to $600.00 and set an “outperform” rating for the company in a report on Monday, July 13th. Twenty-one research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and a consensus target price of $523.46.
View Our Latest Research Report on Intuitive Surgical
Intuitive Surgical Stock Performance
Shares of ISRG opened at $350.06 on Wednesday. The stock has a market cap of $123.98 billion, a PE ratio of 40.10, a price-to-earnings-growth ratio of 2.72 and a beta of 1.46. Intuitive Surgical, Inc. has a fifty-two week low of $342.10 and a fifty-two week high of $603.88. The firm’s 50-day simple moving average is $412.30 and its two-hundred day simple moving average is $464.06.
Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last released its earnings results on Thursday, July 16th. The medical equipment provider reported $2.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.48 by $0.32. Intuitive Surgical had a net margin of 28.45% and a return on equity of 17.09%. The firm had revenue of $2.89 billion during the quarter, compared to analyst estimates of $2.83 billion. During the same period last year, the business earned $1.81 earnings per share. The business’s revenue was up 18.4% on a year-over-year basis. Equities research analysts predict that Intuitive Surgical, Inc. will post 8.61 EPS for the current year.
Intuitive Surgical Profile
Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.
In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.
Read More
- Five stocks we like better than Intuitive Surgical
- Confidence Is Back, But Earnings Show the Consumer Is Being Picky
- AeroVironment’s Stock Is Down, But Drone Demand Is Taking Off
- 3M’s Redemption Arc: Can Q2 Earnings Change the Narrative?
- 3 Photonics Companies Making Quantum Tech Possible
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.
